ONESOURCE SPECIALTY PHARMA LIMITED

Scale -

PBT is 20.29 Rs Cr; Continuous Growth over 3 years; Annual Decline is -37 %
Quarterly Revenue is 449 Rs Cr; Continuous Growth over 3 Quarters
Quarterly Ebitda is 123 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
Quarterly Profit is 25 Rs Cr; Continuous Growth over 3 Quarters
Revenue is 1422 Rs Cr; 5 Year CAGR is 188 %

Ebitda is 319 Rs Cr; Annual Decline is -34 %
PAT is -73.8 Rs Cr; Annual Decline is -311 %; in Bottom Quartile

Profitability -

Quarterly Ebitda Margin is 27 %; Continuous Growth over 3 Quarters
Quarterly Profit margin is 6 %; Continuous Growth over 3 Quarters

PBDIT Margin is 22.45 %; Annual Decline is -33 %
PAT Margin is -5.19 %; Annual Decline is -319 %; in Bottom Quartile

Return -

ROCE is 0.59 %; Annual Decline is -82 %; in Bottom Quartile
ROA is -0.89 %; Annual Decline is -287 %; in Bottom Quartile
ROE is -1.26 %; Annual Decline is -320 %; in Bottom Quartile
Asset Turnover is 18 %; Annual Decline is -45 %

Efficiency -

Operating cash flow is 8.52 Rs Cr; Annual Growth is 113 %; Continuous Growth over 3 years
Current Ratio is 0.99; Continuous Growth over 3 years; 5 Year CAGR is 88 %; in Bottom Quartile
Quick Ratio is 0.68; 5 Year CAGR is 62 %; in Bottom Quartile

Inventory Turnover Ratio is 4.76; Annual Decline is -72 %

Solvancy -

Debt/Equity is 0.22; 5 Year CAGR is -61 %; Annual Growth is 69 %

Long term Debt is 564 Rs Cr; Annual Growth is 157 %; in Top Quartile; 5 Year CAGR is 44 %
Total Debt is 1276 Rs Cr; Annual Growth is 65 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 51 %
Contingent Liabilities is 1570 Rs Cr; Continuous Growth over 3 years; in Top Quartile

Quality -

Operating cashflow/ebitda is 3 %; Annual Growth is 119 %; 5 Year CAGR is -86 %
Exceptional Items/PBT is 11 %; Annual Decline is -93 %; 5 Year CAGR is -42 %; in Top Quartile
Change in Inventories/Total Expenses is 1 %; Annual Decline is -76 %; in Top Quartile
Current Tax/PAT is -3 %; in Bottom Quartile; Annual Growth is 95 %

Operating cashflow/PAT is -12 %; Annual Decline is -103 %

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: